News Conference News EAS 2020 Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention Michael O'Riordan October 08, 2020
News Daily News Obesity’s Role in COVID-19 Deaths: ‘Profound’ and Independent of CVD Shelley Wood August 14, 2020
News Daily News CV Prevention Meds Underused in Hispanic, Latinx PAD Patients L.A. McKeown August 12, 2020
News Daily News New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts Michael O'Riordan August 06, 2020
News Daily News ‘Watchful Waiting’ Spells More Death in Asymptomatic AS, Meta-analysis Confirms L.A. McKeown July 17, 2020
News Daily News Rural-Urban Gap Widens for Cardiometabolic Health Disparities Michael O'Riordan June 22, 2020
News Daily News Obesity’s Role in COVID-19 Deaths: Big Food, Slow Government to Blame? Shelley Wood June 11, 2020
News Daily News AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives Yael L. Maxwell May 29, 2020
News Daily News US Poverty Drives CVD in Low-Income Adults Beyond Traditional Risk Factors L.A. McKeown May 28, 2020
News Features COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention Michael O'Riordan April 24, 2020
News Daily News Adherence to Healthy Habits Linked to Years Free of Chronic Disease Michael O'Riordan April 08, 2020
News Conference News ACC 2020 Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach Todd Neale March 28, 2020
News Daily News Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease Michael O'Riordan March 13, 2020
News Daily News LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure Shelley Wood March 10, 2020
News Daily News Nearly Half of Diabetic Patients Struggle to Pay Medical Bills Michael O'Riordan February 12, 2020
News Daily News CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA Shelley Wood January 14, 2020
News Daily News Diabetes Does Not Appear to Hinder FFR Insights for CAD Caitlin E. Cox January 09, 2020
News Daily News Most Secondary Prevention Patients Are Eligible for Multiple Drugs Michael O'Riordan January 03, 2020
News Daily News Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019 Yael L. Maxwell December 20, 2019
News Daily News ‘Stronger’ Evidence That High Lp(a) Concentrations Cause CVD Yael L. Maxwell December 12, 2019